{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T12:34:55Z","timestamp":1717072495936},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,28]]},"DOI":"10.7759\/cureus.18341","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T07:47:27Z","timestamp":1632815247000},"source":"Crossref","is-referenced-by-count":1,"title":["Malignant Peripheral Nerve Sheath Tumor Presenting as Horner\u2032s Syndrome"],"prefix":"10.7759","author":[{"given":"Mohamed","family":"Azharudeen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayachandran","family":"Selvaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivekanandan","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeyakumar","family":"Meyyappan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vamsidhar","family":"Veeranki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03033740","article-title":"Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1","volume":"9","author":"Bilgic B","year":"2003","unstructured":"Bilgic B, Ates LE, Demiryont M, Ozger H, Dizdar Y. Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1. Pathol Oncol Res. 2003, 9:201-205. 10.1007\/BF03033740","journal-title":"Pathol Oncol Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.33139","article-title":"Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service","volume":"152","author":"Evans DG","year":"2010","unstructured":"Evans DG, Howard E, Giblin C, et al.. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A. 2010, 152:327-332. 10.1002\/ajmg.a.33139","journal-title":"Am J Med Genet A"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-3204","article-title":"Neurofibromatosis type 1 revisited","volume":"123","author":"Williams VC","year":"2009","unstructured":"Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL. Neurofibromatosis type 1 revisited. Pediatrics. 2009, 123:124-133. 10.1542\/peds.2007-3204","journal-title":"Pediatrics"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-009-0045-z","article-title":"Current status of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors","volume":"11","author":"Widemann BC","year":"2009","unstructured":"Widemann BC. Current status of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors. Curr Oncol Rep. 2009, 11:322-328. 10.1007\/s11912-009-0045-z","journal-title":"Curr Oncol Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6701478","article-title":"Neurofibromatosis type 1 presenting with Horner's syndrome","volume":"19","author":"Cackett P","year":"2005","unstructured":"Cackett P, Vallance J, Bennett H. Neurofibromatosis type 1 presenting with Horner's syndrome. Eye (Lond). 2005, 19:351-353. 10.1038\/sj.eye.6701478","journal-title":"Eye (Lond)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7727\/wimj.2014.004","article-title":"Horner's syndrome: a case report and review of the pathophysiology and clinical features","volume":"63","author":"Walker L","year":"2014","unstructured":"Walker L, French S. Horner's syndrome: a case report and review of the pathophysiology and clinical features. West Indian Med J. 2014, 63:278-280. 10.7727\/wimj.2014.004","journal-title":"West Indian Med J"},{"key":"ref7","article-title":"Malignant peripheral nerve sheath tumor presenting with Horner's syndrome","volume":"61","author":"Basuthakur S","year":"2013","unstructured":"Basuthakur S, Sengupta A, Bandyopadhyay A, Banerjee A. Malignant peripheral nerve sheath tumor presenting with Horner's syndrome. J Assoc Phys India. 2013, 61:6613.","journal-title":"J Assoc Phys India"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2008.01.002","article-title":"Induction of abnormal proliferation by nonmyelinating Schwann cells triggers neurofibroma formation","volume":"13","author":"Zheng H","year":"2008","unstructured":"Zheng H, Chang L, Patel N, Yang J, Lowe L, Burns DK, Zhu Y. Induction of abnormal proliferation by nonmyelinating Schwann cells triggers neurofibroma formation. Cancer Cell. 2008, 13:117-128. 10.1016\/j.ccr.2008.01.002","journal-title":"Cancer Cell"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/61.8.702","article-title":"Differential NF1, p16, and EGFR patterns by interphase cytogenetics (FISH) in malignant peripheral nerve sheath tumor (MPNST) and morphologically similar spindle cell neoplasms","volume":"61","author":"Perry A","year":"2002","unstructured":"Perry A, Kunz SN, Fuller CE, et al.. Differential NF1, p16, and EGFR patterns by interphase cytogenetics (FISH) in malignant peripheral nerve sheath tumor (MPNST) and morphologically similar spindle cell neoplasms. J Neuropathol Exp Neurol. 2002, 61:702-709. 10.1093\/jnen\/61.8.702","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3116","article-title":"Somatic mutations of SUZ12 in malignant peripheral nerve sheath tumors","volume":"46","author":"Zhang M","year":"2014","unstructured":"Zhang M, Wang Y, Jones S, et al.. Somatic mutations of SUZ12 in malignant peripheral nerve sheath tumors. Nat Genet. 2014, 46:1170-1172. 10.1038\/ng.3116","journal-title":"Nat Genet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3171\/2012.9.JNS101610","article-title":"Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1","volume":"118","author":"Dunn GP","year":"2013","unstructured":"Dunn GP, Spiliopoulos K, Plotkin SR, Hornicek FJ, Harmon DC, Delaney TF, Williams Z. Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1. J Neurosurg. 2013, 118:142-148. 10.3171\/2012.9.JNS101610","journal-title":"J Neurosurg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2010.11.013","article-title":"Non-metastatic unresected paediatric non-rhabdomyosarcoma soft tissue sarcomas: results of a pooled analysis from United States and European groups","volume":"47","author":"Ferrari A","year":"2011","unstructured":"Ferrari A, Miceli R, Rey A, et al.. Non-metastatic unresected paediatric non-rhabdomyosarcoma soft tissue sarcomas: results of a pooled analysis from United States and European groups. Eur J Cancer. 2011, 47:724-731. 10.1016\/j.ejca.2010.11.013","journal-title":"Eur J Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq338","article-title":"First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC soft tissue and bone sarcoma group study","volume":"22","author":"Kroep JR","year":"2011","unstructured":"Kroep JR, Ouali M, Gelderblom H, et al.. First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC soft tissue and bone sarcoma group study. Ann Oncol. 2011, 22:207-214. 10.1093\/annonc\/mdq338","journal-title":"Ann Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.7.1269","article-title":"Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas","volume":"11","author":"Edmonson JH","year":"1993","unstructured":"Edmonson JH, Ryan LM, Blum RH, et al.. Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas. J Clin Oncol. 1993, 11:1269-1275. 10.1200\/JCO.1993.11.7.1269","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70063-4","article-title":"European Organisation and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomized controlled phase 3 trial","volume":"15","author":"Judson I","year":"2014","unstructured":"Judson I, Verweij J, Gelderblom H, et al.. European Organisation and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomized controlled phase 3 trial. Lancet Oncol. 2014, 15:415-423. 10.1016\/S1470-2045(14)70063-4","journal-title":"Lancet Oncol"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2014.00324","article-title":"Radiation therapy in management of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors","volume":"4","author":"Kahn J","year":"2014","unstructured":"Kahn J, Gillespie A, Tsokos M, et al.. Radiation therapy in management of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors. Front Oncol. 2014, 4:324.","journal-title":"Front Oncol"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.4143\/crt.2016.271","article-title":"Outcomes of treatment for malignant peripheral nerve sheath tumors: different clinical features associated with neurofibromatosis type 1","volume":"49","author":"Hwang IK","year":"2017","unstructured":"Hwang IK, Hahn SM, Kim HS, et al.. Outcomes of treatment for malignant peripheral nerve sheath tumors: different clinical features associated with neurofibromatosis type 1. Cancer Res Treat. 2017, 49:717-726.","journal-title":"Cancer Res Treat"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/65273-malignant-peripheral-nerve-sheath-tumor-presenting-as-horners-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:10Z","timestamp":1707507250000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/65273-malignant-peripheral-nerve-sheath-tumor-presenting-as-horners-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,28]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.18341","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,28]]}}}